Skip to main content
Clinical Trials/NCT02974543
NCT02974543
Completed
N/A

Combined Auditory-Somatosensory Stimulation to Alleviate Tinnitus

University of Michigan1 site in 1 country35 target enrollmentSeptember 2014
ConditionsTinnitus

Overview

Phase
N/A
Intervention
Not specified
Conditions
Tinnitus
Sponsor
University of Michigan
Enrollment
35
Locations
1
Primary Endpoint
Change in TFI (Tinnitus Functional Index) After Treatment or Sham Compared to Baseline
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

The purpose of this study is to develop and test a subject operated device to lessen tinnitus (ringing in the ear), based on subject-feedback for stimulus presentation.

Detailed Description

This study consented 35 adult subjects. 21 subjects qualified and were randomized into the study. This project will develop and test a device with the ultimate goal of providing a patient operated device to alleviate phantom sound perception, or tinnitus, based on patient-feedback for stimulus presentation. The device, an electrical-acoustical stimulus timing, is based on physiological findings of stimulus-timing-dependent plasticity in somatosensory and auditory nuclei,that when aberrant, contribute to tinnitus.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
June 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Crossover
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Susan E. Shore

Professor, Otolaryngology, Molecular and Integrative Physiology; Professor, Biomedical Engineering Kresge Hearing Research Institute The Joseph Hawkins Collegiate Research Professor

University of Michigan

Eligibility Criteria

Inclusion Criteria

  • Constant, subjective, preferably unilateral tinnitus without any active external or middle ear pathology.
  • Hearing thresholds better than 50dB HL at peak tinnitus frequencies.
  • Able to modulate their tinnitus with a somatic maneuver
  • BothersomeTinnitus.

Exclusion Criteria

  • No participation in a tinnitus treatment regimen within the past four weeks
  • Retrocochlear pathology/ VIIIth nerve lesion

Outcomes

Primary Outcomes

Change in TFI (Tinnitus Functional Index) After Treatment or Sham Compared to Baseline

Time Frame: Four weeks on treatment (or sham)

Change in TFI score (mean of weekly assessments for 4 weeks) from baseline for treatment and sham groups. TFI is a clinical questionnaire that assesses tinnitus impact on a subject's quality of life. It uses a scale of 0 - 100 where 0 means no negative impact on quality of life from tinnitus and 100 is devastating impact It will be administered weekly through out the study.

Change in Tinnitus Loudness as Assessed by TinnTester

Time Frame: 4 weeks on treatment (or sham)

Change in Tinnitus matching loudness score (mean of weekly assessments for 4 weeks) from baseline tinnitus matching loudness score, for treatment and sham groups. Subjects are guided through a self-directed computerized assessment software that estimates how loud (in decibels) they perceive their tinnitus to be (TinnTester). This measure was performed at baseline, as well as time points following active, washout, or sham periods.

Study Sites (1)

Loading locations...

Similar Trials